Metabolic HealthMar 15, 2026
Trimethylglycine (TMG) is one of those compounds that does a lot of heavy lifting in your body without getting much credit. It serves as both a cell protector and a methyl donor, two roles that touch everything from liver health to cardiovascular function. The biochemistry is solid, the animal data are extensive, and a handful of human studies point to real benefits for fatty liver and exercise performance. The gap? Large, long-term clinical trials are still missing for most of the conditions TMG might help.
TMG is a natural metabolite of choline, found abundantly in beets, spinach, wheat, and many other foods. Your body also makes it from choline, with the highest concentrations showing up in the kidney, liver, and brain. You're already consuming some from your diet. The question is whether supplementing more of it makes a meaningful difference.
Weight LossMar 15, 2026
Most people trying 16:8 fasting want to know one thing: what will actually be different in a month? The honest answer from clinical trials is that the changes are real but modest. Overweight adults who stick with a 16-hour fast and 8-hour eating window for about four weeks typically lose roughly 1 to 2 kilograms, with small but measurable improvements in insulin sensitivity and triglycerides. That's not nothing. But it's also not dramatic, and it depends heavily on whether you actually eat less overall.
The less comfortable truth is that the eating window itself isn't magic. Several large trials found that when people kept their total calorie intake the same, weight loss from 16:8 looked no different from ordinary dieting. The window works primarily because it makes it easier to eat less. If it doesn't do that for you, the scale probably won't move much.
InsulinMar 15, 2026
NPH insulin has an image problem. It is older, cloudier, and requires more hands-on effort than the long-acting analogs that dominate modern prescribing. Yet the research paints a more nuanced picture: in type 2 diabetes, real-world data show similar or even better A1c results with NPH compared to pricier alternatives, and no reduction in serious hypoglycemia with those newer insulins. At 2 to 10 times less cost, NPH remains a genuinely effective basal insulin for a large number of people. The catch is that it demands more from the person using it.
Understanding where NPH truly falls short, and where the gap with analogs barely matters, can help you have a more honest conversation with your provider about what belongs in your regimen.
Acid-Base BalanceMar 15, 2026
A low CO₂ result on a standard blood panel can mean your body is struggling with a serious acid-base problem. Or it can mean the lab tech left your blood sample sitting uncapped too long. The value can drop more than 20% just from how the tube was handled before testing, which means the number on your report may not reflect what's actually happening inside your body.
That's the core tension with this particular lab value. CO₂ on a basic metabolic panel is really measuring bicarbonate, a buffer your blood uses to keep its pH stable. When it's genuinely low, it points to real problems. But it's also one of the more error-prone numbers on a routine panel, and interpreting it without context can lead you (or even your doctor) down the wrong path.
Kidney HealthMar 15, 2026
Most people glance at their lab results and focus on whether individual numbers are "normal." But the BUN/creatinine ratio, a simple calculation your doctor can derive from two standard blood tests, tells a surprisingly rich story about your kidneys, hydration, and even your risk of dying from heart failure, stroke, or critical illness. The most striking finding: the relationship between this ratio and mortality is U-shaped. People with ratios in the sweet spot of roughly 11 to 15 have the lowest risk, while those on either extreme, very high or very low, face higher all-cause death rates.
That makes it one of the cheapest and most widely available risk signals in medicine, hiding in plain sight on routine bloodwork.
ProbioticsMar 15, 2026
A single randomized controlled trial gave pasteurized Akkermansia muciniphila to overweight, insulin-resistant adults for three months. The results were genuinely impressive: insulin sensitivity improved roughly 29%, fasting insulin dropped, total cholesterol fell, and participants lost modest amounts of weight and fat mass. Short-term safety looked good. That's the best news this bacterium has going for it right now, and it's worth taking seriously.
It's also worth taking carefully. That one trial is, so far, the only controlled human experiment with direct Akkermansia supplementation. The rest of the evidence comes from animal research and observational data, and some of it raises real concerns about who might be helped and who might be harmed.
NutritionMar 15, 2026
Diet Coke has become more than a beverage; it’s a cultural icon, shorthand for restraint, modernity, and sometimes quiet denial. It sits in meetings beside salads and laptops, its fizz whispering reassurance: You’re being good. Yet for decades, that promise has been shadowed by suspicion. Can something that tastes so much like sugar truly come without a cost?
The question isn’t new. Since Diet Coke’s debut in 1982, its central ingredient (artificial sweeteners) has been the subject of relentless scrutiny. Studies have alternately claimed these compounds help with weight control, trigger metabolic chaos, or even mimic the effects of sugar itself. As the evidence piles up, one truth has become clear: the story of Diet Coke is less about chemistry and more about context.
Cholesterol ManagementMar 15, 2026
Most people think of HDL as the "good cholesterol" and assume more is better. But the protein that makes HDL work, apolipoprotein A1 (ApoA1), tells a more complicated story. Research shows that both very low and very high levels of ApoA1 are linked to increased mortality, creating a U-shaped risk curve that challenges the simple "higher is healthier" assumption. Even more striking: ApoA1 can become oxidized inside arterial plaques, flipping from a protective molecule into one that actively promotes inflammation.
This shift in understanding, from how much ApoA1 you have to how well it actually functions, is reshaping how researchers think about cardiovascular risk and treatment.
Liver HealthMar 15, 2026
A compound made by your intestinal bacteria, not your own cells, is emerging as a surprisingly sensitive marker for severe liver disease and metabolic dysfunction. Urobilinogen, a breakdown product of the bile pigment bilirubin, shows up on routine urine dipsticks and is often ignored. But recent research ties elevated levels in the blood to early mortality in alcohol-related hepatitis and to insulin resistance, suggesting this "waste product" deserves a closer look.
What makes urobilinogen especially interesting is that it sits at the intersection of your liver, your gut microbiome, your kidneys, and your metabolism. Its levels don't just reflect one organ. They reflect how well an entire system is working.
Body CompositionMar 15, 2026
BMI has been the go-to metric for assessing and tracking health for decades, but can also be a bit of a BS metric. It oversimplifies your body's complexities by treating muscle and fat as interchangeable, ignoring fat distribution, and overlooking key factors like your unique genetics, age, and lifestyle. This one-size-fits-all approach often misclassifies health, masking real risks like visceral fat or metabolic dysfunction while mislabeling healthy individuals as overweight.
Urinary HealthMar 15, 2026
The most common medications for overactive bladder work well enough, but a huge number of people stop taking them. The reason is straightforward: anticholinergic side effects like dry mouth, constipation, and cognitive concerns make the treatment feel almost as burdensome as the problem. Myrbetriq (mirabegron) works through an entirely different mechanism, a β3-adrenergic agonist rather than an antimuscarinic, and that distinction matters in daily life. Multiple large phase III trials show it delivers comparable bladder symptom relief with significantly fewer of those deal-breaker side effects.
That practical advantage is why Myrbetriq has carved out a clear role, not as a revolutionary leap in effectiveness, but as a medication people are more likely to keep using long enough for it to help.
Metabolic HealthMar 15, 2026
For decades, metformin was the unassuming workhorse of type 2 diabetes care. Cheap, safe, and effective, it quietly helped millions regulate blood sugar long before “metabolic health” became a buzzword. But in recent years, researchers and clinicians have started asking a new question: could this modest pill also help with weight loss, and if so, could those results last without harming the body’s metabolic balance?
This question comes at a time when society is fascinated by pharmaceutical weight loss. New drugs that reshape appetite and energy use are being hailed as breakthroughs. Metformin, by contrast, represents something subtler: a treatment that coaxes the metabolism toward balance instead of forcing it into overdrive. The challenge is to determine whether this gentler approach produces results that endure.
Weight LossMar 15, 2026
If you have obstructive sleep apnea (OSA) and you're carrying extra weight, you've probably heard the standard advice: lose weight and it'll get better. Easier said than done. So when a drug like Zepbound (tirzepatide) comes along and helps people lose significant weight, a natural question follows: could it actually improve your sleep apnea too?
The short answer is yes, it can make a meaningful difference. Multiple clinical analyses published in 2025 consistently show that GLP-1/GIP drugs like tirzepatide reduce the number of times your breathing stops or gets dangerously shallow each hour while you sleep. But before you start thinking you can toss your CPAP machine, there are some important caveats. This article breaks down how much improvement you can realistically expect and whether these medications could be right for your situation.
InsulinMar 15, 2026
You probably know your blood pressure and cholesterol levels. But chances are, you’ve never thought about your fasting insulin levels. As we age, our bodies change in subtle ways long before symptoms emerge. Muscles weaken. Blood vessels stiffen. Metabolism slows. One of the most telling and overlooked signals of these changes is how our bodies handle insulin.
Insulin is the hormone that tells your cells what to do with the food you eat. When it doesn’t work properly, the entire metabolic system begins to sputter. That’s why a simple fasting insulin test might offer an early glimpse into your body’s metabolic trajectory and your risk of chronic disease in the years ahead.
Cardiovascular HealthMar 15, 2026
Barberry's main alkaloid, berberine, has strong clinical trial evidence for lowering blood lipids and improving insulin resistance. That part is well established across multiple randomized controlled trials. The strange part: berberine has less than 1% oral bioavailability, meaning almost none of what you swallow actually reaches your bloodstream in its original form. It gets extensively metabolized before it can circulate, yet the clinical results keep showing up anyway.
This makes barberry one of the more interesting plants sitting at the intersection of traditional medicine and modern metabolic research. The fruit has a long culinary history, particularly in Persian cuisine where it's known as zereshk. The roots and bark pack the heaviest concentration of berberine. And the gap between the compound's poor absorption and its measurable effects in humans is something researchers are still working to explain.
NutritionMar 15, 2026
Intermittent fasting has been widely embraced as a straightforward yet effective approach to weight management. Unlike traditional diets that dictate what to eat, this diet focuses on when you eat. But does the science truly back up the hype?
NutritionMar 15, 2026
In today's world of ultra-addictive foods, the average American is practically overdosing on sugar. While the damage may not be immediately obvious, these sugar spikes cause inflammation and eventually snowball into serious conditions like insulin resistance, diabetes, and heart disease.
For most patients at Instalab, this isn't news. We all know sugar is bad for us. But willpower is finite, and swearing off all sweet-tasting foods forever isn't a sustainable plan. Instead, we recommend finding an alternative that gives you the sweetness you crave without wreaking havoc on your metabolism and cardiovascular system.
SupplementationMar 15, 2026
Isolated soluble fibers, the same types used in most fiber gummies (inulin, fructooligosaccharides, resistant starch), produce small but measurable improvements in body weight, blood sugar, and body composition. In adults with overweight or obesity, these fiber supplements reduced body weight by roughly 2.5 kg, along with improvements in BMI, body fat, fasting glucose, and insulin, over study periods ranging from 2 to 17 weeks.
That's a genuine effect, not a marketing fantasy. But it's also not the whole story. Most of the big, impressive health associations tied to fiber come from diets rich in whole plant foods, which bundle fiber with micronutrients and phytochemicals that an isolated supplement simply doesn't contain. Fiber gummies occupy a real but narrow lane.
PCOSMar 15, 2026
If you have PCOS and feel like fat gravitates to your midsection no matter what you do, you're not imagining it. Research consistently shows that women with PCOS accumulate more abdominal fat than women without it, even when they weigh the same overall. This pattern has a name in online communities ("PCOS belly"), and while that's not a medical diagnosis, the science behind it is real and worth understanding.
PCOS belly isn't just a cosmetic concern. It's driven by a specific hormonal and metabolic loop involving insulin resistance and excess androgens, and it independently raises your risk for type 2 diabetes, metabolic syndrome, and cardiovascular disease. The good news is that targeted lifestyle changes (and, when needed, certain medications) can break that cycle.
Metabolic HealthMar 15, 2026
Standard berberine is one of the most poorly absorbed supplements people actually spend money on. Berberine phytosome, a phospholipid complex designed to solve that problem, delivers roughly 10 times more berberine into the bloodstream than plain berberine in healthy humans, with no additional side effects. That's a meaningful pharmacokinetic leap, and the early clinical trials using this formulation show real metabolic improvements in the short term.
The catch: human data still max out at about three months, and the conditions studied so far are narrow. So you're looking at a supplement with a genuinely better delivery system and promising early results, but without the long-term evidence to match the enthusiasm surrounding it.
